Optimizing frontline therapy in advanced urothelial cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kwon, Whi-An | - |
dc.contributor.author | Seo, Ho Kyung | - |
dc.date.accessioned | 2022-07-08T01:07:10Z | - |
dc.date.available | 2022-07-08T01:07:10Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2020-06 | - |
dc.identifier.issn | 2223-4683 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/145616 | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | AME PUBL CO | - |
dc.title | Optimizing frontline therapy in advanced urothelial cancer | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kwon, Whi-An | - |
dc.identifier.doi | 10.21037/tau.2020.04.03 | - |
dc.identifier.scopusid | 2-s2.0-85090096699 | - |
dc.identifier.wosid | 000548236500004 | - |
dc.identifier.bibliographicCitation | TRANSLATIONAL ANDROLOGY AND UROLOGY, v.9, no.3, pp.983 - 985 | - |
dc.relation.isPartOf | TRANSLATIONAL ANDROLOGY AND UROLOGY | - |
dc.citation.title | TRANSLATIONAL ANDROLOGY AND UROLOGY | - |
dc.citation.volume | 9 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 983 | - |
dc.citation.endPage | 985 | - |
dc.type.rims | ART | - |
dc.type.docType | Editorial Material | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalResearchArea | Urology & Nephrology | - |
dc.relation.journalWebOfScienceCategory | Andrology | - |
dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
dc.subject.keywordPlus | CISPLATIN-INELIGIBLE PATIENTS | - |
dc.subject.keywordPlus | SINGLE-ARM | - |
dc.subject.keywordPlus | MULTICENTER | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordPlus | CHEMOTHERAPY | - |
dc.subject.keywordPlus | PEMBROLIZUMAB | - |
dc.subject.keywordPlus | ATEZOLIZUMAB | - |
dc.subject.keywordPlus | GEMCITABINE | - |
dc.subject.keywordPlus | PACLITAXEL | - |
dc.identifier.url | https://tau.amegroups.com/article/view/40828/html | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.